Literature DB >> 3371309

Quality of life post-myocardial infarction: effects of a transtelephonic coronary intervention system.

M J Follick1, L Gorkin, T W Smith, R J Capone, J Visco, D Stablein.   

Abstract

The impact of an outpatient, risk-management system, including a transtelephonic electrocardiographic monitor and lidocaine injector, on the quality of life in post-myocardial infarction patients was examined. Patients (n = 238) were assigned randomly to either the system or to standard medical care (control). Quality of life was defined in terms of psychological status, return to work, and social functioning. Relative to control patients, system patients showed a significant decrease in concerns about physical functioning and symptoms, and, over time, reported less depressive affect. At 9-month follow-up, control patients were more than twice as likely to be in the range of clinical depression. Patients' perceptions of their ability to manage a recurrence of cardiac symptoms appeared to be related inversely to depressive affect. Moreover, a larger percentage of system patients (92%) had returned to work by the 9-month follow-up, compared with control patients (76%). There were, however, no significant differences between groups in the degree of impairment in social interaction. Overall, these results indicate that the use of a "system" encouraging patient participation in treatment can significantly improve qualify of life after a myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3371309     DOI: 10.1037//0278-6133.7.2.169

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  6 in total

Review 1.  Review of quality-of-life evaluations in patients with angina pectoris.

Authors:  A Gandjour; K W Lauterbach
Journal:  Pharmacoeconomics       Date:  1999-08       Impact factor: 4.981

Review 2.  Prevalence of depression in survivors of acute myocardial infarction.

Authors:  Brett D Thombs; Eric B Bass; Daniel E Ford; Kerry J Stewart; Konstantinos K Tsilidis; Udita Patel; James A Fauerbach; David E Bush; Roy C Ziegelstein
Journal:  J Gen Intern Med       Date:  2006-01       Impact factor: 5.128

3.  Interventions to support return to work for people with coronary heart disease.

Authors:  Janice Hegewald; Uta E Wegewitz; Ulrike Euler; Jaap L van Dijk; Jenny Adams; Alba Fishta; Philipp Heinrich; Andreas Seidler
Journal:  Cochrane Database Syst Rev       Date:  2019-03-14

4.  Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure.

Authors:  Wei Jiang; Christopher O'Connor; Susan G Silva; Maragatha Kuchibhatla; Michael S Cuffe; Dwayne D Callwood; Bosh Zakhary; Elizabeth Henke; Rebekka M Arias; Ranga Krishnan
Journal:  Am Heart J       Date:  2008-07-07       Impact factor: 4.749

5.  Quality of life among patients post-myocardial infarction at baseline in the Survival and Ventricular Enlargement (SAVE) trial.

Authors:  L Gorkin; M J Follick; E Geltman; P Hamm; J Sollano; S Sylvia; K Jacobson; M J Jacobson; B S Cochrane; B Sussex
Journal:  Qual Life Res       Date:  1994-04       Impact factor: 4.147

6.  Association between Obsessive-Compulsive Symptoms and Long-Term Cardiac Outcomes in Patients with Acute Coronary Syndrome: Effects of Depression Comorbidity and Treatment.

Authors:  Hee-Joon Lee; Ju-Wan Kim; Hee-Ju Kang; Sung-Wan Kim; Il-Seon Shin; Young-Joon Hong; Young-Keun Ahn; Myung-Ho Jeong; Jin-Sang Yoon; Jae-Min Kim
Journal:  Psychiatry Investig       Date:  2019-11-06       Impact factor: 2.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.